Updated: January 18, 2026
Konvomep Availability Update: What Patients Need to Know in 2026
Author
Peter Daggett

Overview
Konvomep (omeprazole/sodium bicarbonate oral suspension) is available but hard to find at many pharmacies. Here's what patients need to know about access in 2026.
Is Konvomep in stock near you?
Medfinder checks real pharmacy inventory — start a search and we'll find Konvomep near you.
Konvomep (omeprazole and sodium bicarbonate for oral suspension) is manufactured and available in the U.S. supply chain in 2026—but that doesn't mean you'll find it on the shelf at your nearest pharmacy. Here's a clear, up-to-date picture of where Konvomep availability stands and what you can do if you're struggling to fill your prescription.
Is Konvomep in a Shortage in 2026?
As of 2026, Konvomep does not appear on the FDA's official drug shortage list. Azurity Pharmaceuticals continues to manufacture and distribute the medication. However, "not in an official shortage" and "easy to find" are not the same thing. Konvomep presents real-world availability challenges that patients encounter daily.
Check live stock now.
Why Konvomep Is Difficult to Find Despite No Formal Shortage
The availability challenges with Konvomep come from its unique characteristics as a product:
Specialty status. Konvomep is a specialty oral suspension, not a mass-market pill. It serves patients who can't swallow pills—a smaller group than general PPI users.
Refrigeration requirements. The reconstituted suspension must be stored at 36–46°F and discarded after 30 days, creating logistical challenges for many retail pharmacies.
No generic equivalent. Without a generic to drive competition and widespread distribution, Konvomep remains a single-source brand product with more limited distribution infrastructure.
Recent market entry. Konvomep became commercially available only in early 2023. Pharmacy ordering patterns take time to adjust to newer specialty medications.
What Type of Patient Needs Konvomep?
Konvomep is prescribed for adult patients who:
Have difficulty swallowing capsules or tablets (dysphagia)
Are being treated for an active benign gastric ulcer (FDA-approved indication)
Need acid suppression via nasogastric or orogastric tube at home after a hospital stay
Are transitioning from IV acid suppression in the ICU and need a comparable oral liquid formulation
How Patients Are Dealing With Konvomep Access Issues
Patients dealing with Konvomep availability challenges in 2026 are using several approaches:
Calling ahead. Patients who know Konvomep isn't universally stocked call multiple pharmacies before leaving home to confirm availability.
Using hospital outpatient pharmacies. These pharmacies see higher volumes of specialty medications and are more likely to carry Konvomep.
Requesting special orders. Even pharmacies that don't regularly stock Konvomep can often order it through their drug wholesaler within 24–48 hours.
Using medfinder. Rather than spending hours calling pharmacies themselves, some patients use medfinder to have pharmacies contacted on their behalf.
What to Tell Your Doctor About Availability
If you're having a hard time filling your Konvomep prescription, communicate this to your prescriber immediately—especially if you're running low on medication. Your doctor has options: they can contact a specialty pharmacy directly, write a prescription for an equivalent alternative, or provide documentation to help you navigate insurance and access barriers. Don't wait until you're out of medication to have this conversation.
Using medfinder to Find Konvomep
medfinder is a paid service that calls pharmacies in your area to check which ones can fill your Konvomep prescription. You provide your medication details and ZIP code—medfinder makes the calls and texts you the results. This is especially useful when you're dealing with a specialty medication that requires multiple pharmacy calls.
Found
Rate
on average
What to Expect Going Forward
As awareness of Konvomep grows among prescribers and patients, pharmacy stocking should gradually improve. Until then, the most reliable approach is a combination of proactive pharmacy searching, special ordering requests, and using resources like medfinder to streamline the process. See our full guide on how to find Konvomep in stock near you for a step-by-step approach.
Frequently Asked Questions
As of 2026, Konvomep does not appear on the FDA's official drug shortage list. Azurity Pharmaceuticals continues to manufacture and distribute the drug. However, it remains difficult to find at many retail pharmacies due to its specialty liquid formulation, refrigeration requirements, and limited stocking by most pharmacies.
Konvomep's availability challenges stem from its specialty nature: it requires pharmacist reconstitution, cold storage at 36–46°F, and has a 30-day shelf life after mixing. Most retail pharmacies don't stock low-volume specialty liquids unless there is predictable local demand, which creates access gaps even without a formal manufacturing or supply shortage.
Konvomep was FDA-approved on August 30, 2022, and began commercial distribution at pharmacies nationwide in Q1 2023. As a relatively recent entrant to the market, many pharmacies have not yet incorporated it into their standard ordering patterns, contributing to limited availability.
Contact your prescriber as soon as possible if you're running low on Konvomep. Don't wait until you've run out. Your doctor can help by calling a specialty pharmacy, providing documentation for insurance approval, or prescribing an appropriate alternative such as Zegerid or a compounded omeprazole suspension while you locate the medication.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Konvomep also looked for:
More about Konvomep
39,333 have already found their meds with Medfinder.
Start your search today.
Your information is private and never shared.





